Lexicon Pharmaceuticals (NASDAQ:LXRX) Upgraded at StockNews.com

StockNews.com upgraded shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) to a sell rating in a report released on Saturday morning. Separately, Jefferies Financial Group initiated coverage on shares of Lexicon Pharmaceuticals in a report on Tuesday, March 7th. They issued a hold rating and a $3.00 price objective for the company. Lexicon Pharmaceuticals Trading […]

Related Keywords

Montreal ,Quebec ,Canada , ,Jefferies Financial Group ,Virtu Financial ,Institutional Investors Weigh In On Lexicon Pharmaceuticals ,Lexicon Pharmaceuticals Inc ,Manufacturers Life Insurance Company ,Lexicon Pharmaceuticals Trading ,News Ratings For Lexicon Pharmaceuticals Daily ,Lexicon Pharmaceuticals ,Acrisure Capital Management ,Tower Research Capital ,Get Rating ,Montreal Can ,Capital Management ,Research Capital ,Lexicon Pharmaceuticals Daily ,Nasdaq Lxrx ,Lxrx ,Medical ,52887210 ,Upgrade ,Stocknews Com ,